Director records verified

Rajesh Mahajan

Named in 18 filings across 1 BSE-listed company since 2025-09 — most recently at Brooks Laboratories Ltd (2026-10).
Records through 2026-10-14 · refreshed as new filings arrive
Seen in filings at (from BSE disclosures)
Brooks Laboratories Ltd
kmp
18 filings · 2025-09 – 2026-10
Documented roles (from public records)
Brooks Laboratories Ltd
co-founder/Managing Director, later President – Trading · 2002–Nov 2022 (MD); reappointed senior management July 2026
Qalys Pharma LLP
Designated Partner
Common questions (from the filings record)
Who is Rajesh Mahajan in BSE filings?
Rajesh Mahajan is named in 18 filings across 1 BSE-listed company since 2025-09 — most recently at Brooks Laboratories Ltd (2026-10). Records through 2026-10-14, from public exchange disclosures.
Which companies is Rajesh Mahajan named in?
Brooks Laboratories Ltd (kmp) — 18 filings, 2025-09 to 2026-10.
What documented roles does Rajesh Mahajan hold?
From BSE filings: kmp at Brooks Laboratories Ltd. From public records: Brooks Laboratories Ltd — co-founder/Managing Director, later President – Trading, 2002–Nov 2022 (MD); reappointed senior management July 2026; Qalys Pharma LLP — Designated Partner.
Track record, connections and full analysis — on the Bench
The Bench shows this person's documented history, their connections across listed companies, and what happened after their filings.
Special Situations Bench a Humdinger HQ product
Compiled from public exchange disclosures and public records. situations.humdingerhq.ai is not a SEBI-registered research analyst; nothing here is investment advice. Corrections: via Humdinger HQ.